...
首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan–carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating
【24h】

Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan–carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating

机译:基于原位形成的聚电解质复合膜包衣的壳聚糖-卡波姆基质片剂中盐酸文拉法辛的可调性和持续释放特性

获取原文
           

摘要

p id="sp0015"The objective of this study is to design sustained-release tablets using matrix technology, which can well control the release of highly water-soluble drugs with good system robustness and simple preparation process. Taking venlafaxine hydrochloride (VH) as a drug model, the feasibility of using chitosan (CS), carbomer (CBM) combination system to achieve this goal was studied. Formulation and process variables influencing drug release from CS–CBM matrix tablets were investigated. It was found that CS–CBM combination system weakened the potential influence of CS, CBM material properties and gastric emptying time on drug release profile. Demonstrated by direct observation, differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR), in situ self-assembled polyelectrolyte complex (PEC) film was formed on the tablet surface during gastrointestinal tract transition, which contributed to the tunable and robust control of drug release. The sustained drug release behavior was further demonstrated in vivo in Beagle dogs, with level A in vitro and in vivo correlation (IVIVC) established successfully. In conclusion, CS–CBM matrix tablets are promising system to tune and control the release of highly water-soluble drugs with good system robustness.
机译:id =“ sp0015”>这项研究的目的是使用基质技术设计缓释片剂,该技术可以很好地控制高水溶性药物的释放,并具有良好的系统稳定性和简单的制备过程。以盐酸文拉法辛(VH)为药物模型,研究了使用壳聚糖(CS),卡波姆(CBM)组合系统实现此目标的可行性。研究了影响CS-CBM基质片剂释放的制剂和工艺变量。结果发现,CS-CBM组合系统减弱了CS,CBM物质特性和胃排空时间对药物释放曲线的潜在影响。通过直接观察,差示扫描量热法(DSC)和傅里叶变换红外光谱(FTIR)证明,胃肠道过渡过程中在片剂表面上形成了原位自组装聚电解质复合物(PEC)膜,这有助于控制的可调性和鲁棒性药物释放。在比格犬体内进一步证明了持续的药物释放行为,并成功建立了A级体外和体内相关性(IVIVC)。总之,CS–CBM基质片剂是一种有前途的系统,具有良好的系统稳健性,可以调节和控制高度水溶性药物的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号